258 related articles for article (PubMed ID: 28507435)
1. Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner.
Orlando A; Cazzaniga E; Tringali M; Gullo F; Becchetti A; Minniti S; Taraballi F; Tasciotti E; Re F
Int J Nanomedicine; 2017; 12():3547-3559. PubMed ID: 28507435
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanoparticles as a compound delivery system in zebrafish embryos.
Sharif F; Porta F; Meijer AH; Kros A; Richardson MK
Int J Nanomedicine; 2012; 7():1875-90. PubMed ID: 22605936
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum.
Shahabi S; Döscher S; Bollhorst T; Treccani L; Maas M; Dringen R; Rezwan K
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26880-91. PubMed ID: 26562468
[TBL] [Abstract][Full Text] [Related]
5. Silica nanoparticles induce autophagy and endothelial dysfunction via the PI3K/Akt/mTOR signaling pathway.
Duan J; Yu Y; Yu Y; Li Y; Wang J; Geng W; Jiang L; Li Q; Zhou X; Sun Z
Int J Nanomedicine; 2014; 9():5131-41. PubMed ID: 25395850
[TBL] [Abstract][Full Text] [Related]
6. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
7. Two distinct cellular pathways leading to endothelial cell cytotoxicity by silica nanoparticle size.
Lee K; Lee J; Kwak M; Cho YL; Hwang B; Cho MJ; Lee NG; Park J; Lee SH; Park JG; Kim YG; Kim JS; Han TS; Cho HS; Park YJ; Lee SJ; Lee HG; Kim WK; Jeung IC; Song NW; Bae KH; Min JK
J Nanobiotechnology; 2019 Feb; 17(1):24. PubMed ID: 30722792
[TBL] [Abstract][Full Text] [Related]
8. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
Baeza A; Colilla M; Vallet-Regí M
Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
[TBL] [Abstract][Full Text] [Related]
9. Uptake kinetics and nanotoxicity of silica nanoparticles are cell type dependent.
Blechinger J; Bauer AT; Torrano AA; Gorzelanny C; Bräuchle C; Schneider SW
Small; 2013 Dec; 9(23):3970-80, 3906. PubMed ID: 23681841
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Effect of α-Tocopheryl Succinate Delivered by Mitochondria-Targeted Mesoporous Silica Nanoparticles.
Qu Q; Ma X; Zhao Y
ACS Appl Mater Interfaces; 2016 Dec; 8(50):34261-34269. PubMed ID: 27998109
[TBL] [Abstract][Full Text] [Related]
11. Cellular Toxicity of Mesoporous Silica Nanoparticle in SHSY5Y and BMMNCs Cell.
Chauhan S; Manivasagam G; Kumar P; Ambasta RK
Pharm Nanotechnol; 2018; 6(4):245-252. PubMed ID: 30381088
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Mesoporous Silica Nanoparticles for Targeted Drug Delivery Applications.
Abu-Dief AM; Alsehli M; Al-Enizi A; Nafady A
Curr Drug Deliv; 2022; 19(4):436-450. PubMed ID: 34238185
[TBL] [Abstract][Full Text] [Related]
14. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution.
Shao D; Lu MM; Zhao YW; Zhang F; Tan YF; Zheng X; Pan Y; Xiao XA; Wang Z; Dong WF; Li J; Chen L
Acta Biomater; 2017 Feb; 49():531-540. PubMed ID: 27836804
[TBL] [Abstract][Full Text] [Related]
15. Toxicity evaluation of mesoporous silica particles Santa Barbara No. 15 amorphous in human umbilical vein endothelial cells: influence of particle morphology.
Teng W; Yang Z; Wang S; Xiong D; Chen Y; Wu Z
J Appl Toxicol; 2021 Sep; 41(9):1467-1478. PubMed ID: 33438233
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.
Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR
Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells.
Torabi M; Aghanejad A; Savadi P; Barzegari A; Omidi Y; Barar J
Bioimpacts; 2023; 13(3):255-267. PubMed ID: 37431477
[TBL] [Abstract][Full Text] [Related]
18. Functionalization of mesoporous silica nanoparticles with a cell-penetrating peptide to target mammalian sperm in vitro.
Barkalina N; Jones C; Townley H; Coward K
Nanomedicine (Lond); 2015 May; 10(10):1539-53. PubMed ID: 26008192
[TBL] [Abstract][Full Text] [Related]
19. ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood-brain barrier.
Shen Y; Cao B; Snyder NR; Woeppel KM; Eles JR; Cui XT
J Nanobiotechnology; 2018 Feb; 16(1):13. PubMed ID: 29433522
[TBL] [Abstract][Full Text] [Related]
20. Polyethylenimine-mediated synthetic insertion of gold nanoparticles into mesoporous silica nanoparticles for drug loading and biocatalysis.
Pandey PC; Pandey G; Narayan RJ
Biointerphases; 2017 Mar; 12(1):011005. PubMed ID: 28347142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
